Даваа–Баасан 08:30–20:00 · Бямба 09:00–16:00
Now showing 1 - 10 of 25
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Study of the CagPAI gene for gastric virulence factor of Helicobacter pylori
    (Thieme Medical Publishers (Germany), 2026-06-01)
    G Baatar
    ;
    O Khasag
    ;
    Aims The Helicobacter pylori ( H. pylori ) is considered as the major cause of gastric cancer. This can be explained by the differences in the genotype of the CagA toxicity and the genes of the CagPAI assembly. Methods A case control study was conducted among Mongolian adult patients. Gastric endoscopy, gastric histology, H. pylori isolation, and its gene sequence were performed in gastric cancer and non-gastric cancer cases. Тhe diagnosis of gastric cancer was determined by the Lawrence classification. After culturing H.pylori infection DNA was extracted. Based on whole genome database the CagPAI complex genes were extracted and statistically processed [ 1 ] [ 2 ] [ 3 ] [ 4 ] [ 5 ] [ 6 ] [ 7 ] [ 8 ]. Results A total of 54 patients were included in the study, with a male-to-female ratio of 1:1. Among the participants, 27.8% (n=15) were diagnosed with gastric cancer and 72.2% (n=39) had non-cancer cases. According to the updated Sydney classification, 66.7% (n=26) of non-cancer cases were low-risk and 33.3% (n=13) were high-risk for gastric cancer. Cancer prevalence differed by sex: 13.3% of women (n=4) and 45.8% of men (n=11) had cancer, indicating a significantly higher risk in men with H. pylori infection (p=0.009). Analysis of the H. pylori CagPAI gene revealed that 64.8% (n=35) of cases had complete gene sequences, 20.4% (n=11) were incomplete, and 14.8% (n=8) were negative. Full CagPAI expression was observed in 46.2% of low-risk, 61.5% of high-risk non-cancer groups, and 100% of cancer cases, demonstrating a significant association with gastric pathology (p=0.005). Full gene expression correlated with tumor presence and increased Sydney scores, reflecting greater histopathological changes in the gastric antrum (monocyte score p<0.0001, neutrophil score p<0.001). Full CagPAI gene expression was associated with a 1.75-fold increased risk of gastric cancer (OR=1.75, 95% CI 1.3–2.3). Individuals over 40 years old with H. pylori infection had a 10.8-fold higher risk (OR=10.8, 95% CI 1.3–90.5), and men with H. pylori infection had a 5.5-fold higher risk compared to women (OR=5.5, 95% CI 1.5–20.7). Conclusions Among H. pylori –positive patients, 66.7%(n=26) of non-cancer cases were low-risk and 33.3%(n=13) were high-risk according to the updated Sydney classification. Full CagPAI gene expression was observed in 46.2%(n=12)of low-risk, 61.5%(n=8) of high-risk, and 100% of cancer cases, indicating a strong association with gastric cancer development ( p=0.005 ). Publication History Article published online: 06 June 2026 © 2026. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Initial results of screening program in Mongolia where burdening high gastric cancer
    (2023-04-17)
    Background: Mongolia is the leading country by the incidence and mortality rate of gastric cancer. In 2022 national cancer screening program for upper gastrointestinal neoplasia was initiated therefore we conducted the multi-center study for determining the gastric cancer among Mongolian population.
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Helicobacter Pylori Genotyping Among Mongolian Dyspeptic Patients
    (Mongolian National University of Medical Sciences, 2022-06-30)
    Tserentogtokh Tegshee
    ;
    ; ; ;
    Battulga Adiyasuren
    Objective: The prevalence of H. pylori infection varies significantly and developing countries are found to be the highest in Asia. In the present study, we have aimed to perform a combined analysis of histochemical stains and IHC to confirm the H.pylori infection of patients in 5 different provinces and Ulaanbaatar city, Mongolia. Method: Five hundred and thirty-eight patients were enrolled in this study (142 gastric mucosal atrophy, 333 gastritis and 62 gastroesophageal reflux). Results: 67.1 % of participants had CagA positive and 69.3 % were immunohistochemically positive. All histological results showed that the gastritis group was significantly higher in patients who were positive for H. pylori than in antral-predominant gastritis. By the hematoxylin and eosin staining with May– Giemsa confirmation by IHC, the prevalence of H. pylori infection in the gastric mucosal atrophy group was 62.1 %, while in the gastritis and gastroesophageal reflux group, the rate was 74.3 % and 59.1 %, respectively. Conclusion: CagA sequence profile in each group of patients revealed that 22.6 % of the gastric mucosal atrophy group was ABC type, 43.4 % was ABCC type and 33.9 % was ABTC type. On the other hand, in the gastritis group, the dominant type was ABTC (41.3 %). In the gastroesophageal reflux group, the ABCC type was dominant while 23.1% was the ABC type.
  • Some of the metrics are blocked by your 
    Item type:Publication,
    1257 ENTEROCCUS HIRAE ATTENUATES CHEMOKINE AND INDUCES DNA DAMAGE IN GASTRIC EPITHELIAL CELLS
    (Elsevier BV, 2023-05-01) ; ;
    Ricky Indra Alfaray
    ;
    Junko K. Akada
    ;
    Takashi Matsumoto
  • Some of the metrics are blocked by your 
    Item type:Publication,
    IDDF2023-ABS-0237 Characteristics of helicobacter pylori from mongolia where burdening high incidence of gastric cancer
    (2023-06-01) ; ; ;
    Yoshio Yamaoka
    ;
    Vo Phuoc Tuan
    Background Globally Mongolia is the top country in the incidence of gastric cancer followed by Japan and Korea which are East Asian countries. Helicobacter pylori (H. pylori) infection possessing East-Asian-type CagA is more associated with gastric carcinogenesis than Western-type CagA. The prevalence of H. pylori is around 70% in Mongolia; however, the previous study reported Mongolians infected with H. pylori possessing Western-type CagA. Therefore, we aimed to characterize Mongolian H. pylori infection based on a whole genome sequencing method. Methods Totally 130 strains are sequenced from Mongolian H. pylori isolates (20 gastric cancer and 110 non-cancer cases) and 401 data from 38 countries H. pylori whole genome data were extracted for the FineStructure analysis. The complete CagA gene and 7 housekeeping genes were extracted for constructing a phylogenetic tree. Results Based on whole genomic FineStructure analysis we found new H. pylori population named as HpMongolia among Mongolian gastric cancer and non-gastric cancer cases which are separately clustered among published global H. pylori populations (IDDF2023-ABS-0237-Figure 1. FineStructure analysis for H.pylori population). Complete CagA gene sequencing data showed that HpMongolia possessed with J-Western type cagA and it was the highest distribution of J-Western cagA positive H. pylori strains identified in Mongolia (67.7%) followed by Canada, North America (10%), and Okinawa, Japan (5.9%) among the published population (IDDF2023-ABS-0237-Figure 2. Global H.pylori phylogenetic tree based on 7-housekeeping genes). The phylogenetic tree constructed based on 7 housekeeping genes result showed the closest H. pylori population with HpMongolia is the HpAmerind which is isolated from native American people (IDDF2023-ABS-0237-Figure 3. H.pylori CagA genotyping map). Conclusions Mongolians provide new H. pylori population is named as HpMongolia which contains most of the cases Japanese-Western type cagA both for cancer and non-cancer cases. Therefore Japanese-Western type cagA might have advantageous for human migration study markers and further clinical implications.
  • Some of the metrics are blocked by your 
    Item type:Publication,
  • Some of the metrics are blocked by your 
    Item type:Publication,
    IDDF2023-ABS-0226 Initial results of screening program in mongolia where burdening high gastric cancer
    Background Mongolia is the leading country in the incidence and mortality rate of gastric cancer. According to the national data, TNM stage at the time of cancer diagnosis, a gastric cancer diagnosis is 0.4% in the carcinoma-in-situ stage, 5.1% in stage I, 15.2% in stage II, 42.7% in stage III and 36.5% in stage IV 36.5% were diagnosed respectively. Whereas almost 80% of people are diagnosed with early-stage of gastric cancer in Japan and Korea, where national cancer screening programs have been initiated for several decades. In 2022 national cancer screening program for upper gastrointestinal neoplasia was initiated; therefore, we aimed to conduct a multi-center study to determine gastric cancer incidence among the Mongolian population. Methods The cross-sectional study was performed to examine the detection rate of gastric cancer cases based on a national screening program from May to December 2022. The primary outcomes of this study were to define the detection rate (proportion of positive cases among individuals who underwent endoscopic screening) and to determine the characteristics of the cancer type, including its precursor disease based on histological examination. Results During the screening program, a total of 34581 participants’ data were collected from 28 endoscopy centers from Ulaanbaatar city and the western eastern, southern, and northern parts of the Mongolian province’s hospitals. The age range of the study participants was 35 to 93 years old. In terms of gender, 56.8% are men and 43.13% are women. The mean with SD age of people diagnosed with gastric cancer was 61.56±1.11, while the mean with SD age of healthy people was 53.84 ± 0.29 (p-value 0.0001). Among them, 113 (0.1%) patients were diagnosed with gastric cancer. The proportion of early-stage gastric cancer cases was 34 (30%) based on endoscopic and histological evaluation. The overall cases included in the national screening program are summarized in Figure 1 (IDDF2023-ABS-0226 Figure 1. Initial result from the national screening program for gastric cancer). Conclusions The initiation of the Mongolian national gastric cancer screening program could increase to detect the proportion of gastric cancer in its early stage. Therefore, screening programs should be continuous further. However, the quality of endoscopic examination should be improved.
  • Some of the metrics are blocked by your 
    Item type:Publication,
  • Some of the metrics are blocked by your 
    Item type:Publication,
    IDDF2022-ABS-0128 A novel pathogen enterococcus hirae induced dysbiosis in the stomach and the genomic instability to promote gastric cancer
    (2022-09-01) ; ;
    Junko K. Akada
    ;
    Takashi Matsumoto
    ;
    Ricky Indra Alfaray
    Background Previous our microbiome analysis indicates that Enterococcus sp. predominance of microbial composition has been determined in patients with gastric cancer (GC) by 16S rRNA metagenomic analysis. We aimed to determine whether this bacterium could promote the emergence and progression of GC. Methods The effects of E. hirae and Helicobacter pylori (clinical strain Mon-Ke2 as control) were assessed in a gastric epithelial cell line (AGS cells). The cell toxicity of AGS cells is identified by lactate dehydrogenase levels. The DNA double-strand breaks (DSBs) were assessed by gamma-H2AX expressions using immunoblotting; and single-cell gel electrophoresis (SCGE). AGS cells were analyzed for the rapid oxygen species (ROS) expressions response after E. hirae and H. pylori infections. Results E. hirae was successfully isolated from the gastric mucosal specimen of a GC patient for the first time. The whole-genome sequence of E. hirae was confirmed by next-generation sequencing. E. hirae-infected AGS cells showed abnormal morphological changes. Infections of E. hirae and H. pylori significantly induced cell death and expression of gH2AX in AGS cells. Besides, the expression of gH2AX and DSBs was confirmed by SCGE comet formation. Interestingly, co-infection of H. pylori and E. hirae had a synergistic effect on the severity of DSBs. E. hirae could induce intranucleus and mitochondrial ROS in AGS cells same as H. pylori. We investigated whether only live E. hirae, or its released factor(s) can cause DNA damage. Supernatant from AGS cells infected with E. hirae could induce the gH2AX, whereas H. pylori required cell adhesion to induce gH2AX. The complete genome of E. hirae totally contained 2570 genes and 10 known virulence factor genes (e.g., Enterococcus pore-forming toxin). Conclusions E. hirae-related dysbiosis in the stomach might increase the risk for GC, resulting in gained the genomic instability of gastric cells, as well as H. pylori infection. Further research investigating the impacts of this pathogen on the human host using the gastric organoid model is needed since several studies have shown that other species of Enterococcus induce cancer-promoting events resulting in DNA damage in gastric/colonic mucosa, and hepatic cells.
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Utility of endoscopic pressure study integrated system for gastroesophageal reflux disease after endoscopic antireflux therapy
    (Wiley, 2025-06)
    Yamamoto, Kazuki
    ;
    Inoue, Haruhiro
    ;
    Tanaka, Ippei
    ;
    Ushikubo, Kei
    ;
    Iwasaki, Miyuki
    OBJECTIVES: The endoscopic pressure study integrated system (EPSIS) measures intragastric pressure (IGP) during esophagogastroduodenoscopy. Previous research demonstrated that EPSIS correlates with the 24-h impedance-pH (MII-pH) test and shows lower maximum IGP (IGP-Max) and a flatter waveform gradient in gastroesophageal reflux disease (GERD) patients, attributed to lower esophageal sphincter dysfunction. Although endoscopic antireflux therapy (EARTh) is effective for GERD, the MII-pH monitoring, the gold standard for assessing treatment outcomes, requires hospitalization and can be a burden. EPSIS offers a noninvasive alternative for evaluating post-EARTh outcomes. This study aimed to assess EPSIS as an additional diagnostic tool in this context. METHODS: We conducted a retrospective analysis of GERD patients who underwent EARTh and were subsequently assessed using EPSIS within 6 months, from May 2018 to April 2024. Changes in IGP parameters, including IGP-Max and waveform gradient, were analyzed pre- and post-EARTh. Additionally, the study examined Hill's Classification following EARTh. RESULTS: Out of 39 patients assessed with EPSIS before and after EARTh, the average age was 55 years (standard deviation [SD] 16.7), with 64.1% male. Postoperative IGP-Max increased from 15.2 mmHg to 18.0 mmHg (P = 0.004), and the pressure gradient improved from 0.16 mmHg/s to 0.28 mmHg/s (P < 0.001). Hill's Classification improved significantly from a mean of 2.2 (SD 0.7) to 1.1 (SD 0.3) (P < 0.001). CONCLUSION: This study indicates that EPSIS is a reliable diagnostic tool for evaluating the effects of EARTh and holds potential as a supplementary tool for assessing GERD treatment outcomes.
    Scopus© Citations 6